PREZISTA 150 MG Oral Tablet
- RxCUI
- 850457
- RxNorm name
- PREZISTA 150 MG Oral Tablet
- Display name
- PREZISTA 150 MG Oral Tablet
- Full name
- PREZISTA 150 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PREZISTA | DARUNAVIR | Janssen Products LP | 814301f9-c990-46a5-b481-2879a521a16f | 2025-08-29 | Warnings, Adverse reactions | 850457 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 814301f9-c990-46a5-b481-2879a521a16f | PREZISTA 150 MG Oral Tablet [PSN] · darunavir 150 MG Oral Tablet [Prezista] [SBD] · Prezista 150 MG Oral Tablet [SY] | 3 | 58 | These highlights do not include all the information needed to use PREZISTA safely and effectively. See Full Prescribing Information for PREZISTA. PREZISTA ® (darunavir) oral suspension PREZISTA ® (darunavir) tablet, for oral use Initial U.S. Approval: 2006 | 20250829 |